Global Blood: Q2 Earnings Snapshot

August 9, 2022 GMT

SOUTH SAN FRANCISCO, Calif. (AP) _ Global Blood Therapeutics Inc. (GBT) on Monday reported a loss of $82.5 million in its second quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of $1.26.

The results did not meet Wall Street expectations. The average estimate of 16 analysts surveyed by Zacks Investment Research was for a loss of $1.19 per share.

The biopharmaceutical company posted revenue of $71.6 million in the period, which topped Street forecasts. Fourteen analysts surveyed by Zacks expected $64.4 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GBT at https://www.zacks.com/ap/GBT